Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis
Federico Oldoni, Damiano Baldassarre, S. Castelnuovo, et al.
Circulation (2018) Vol. 138, Iss. 10, pp. 1000-1007
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Shi‐Hui Law, Mei-Lin Chan, Gopal K. Marathe, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1149-1149
Open Access | Times Cited: 603
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 238
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
Anand Rohatgi, Marit Westerterp, Arnold von Eckardstein, et al.
Circulation (2021) Vol. 143, Iss. 23, pp. 2293-2309
Open Access | Times Cited: 213
Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
Xiao-Hua Yu, Dawei Zhang, Xi‐Long Zheng, et al.
Progress in Lipid Research (2018) Vol. 73, pp. 65-91
Closed Access | Times Cited: 182
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
Robert A. Hegele, Jan Borén, Henry N. Ginsberg, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 8, Iss. 1, pp. 50-67
Open Access | Times Cited: 155
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 136
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
MacRae F. Linton, Patricia G. Yancey, Tao Huan, et al.
Circulation Research (2023) Vol. 132, Iss. 11, pp. 1521-1545
Open Access | Times Cited: 45
Genetic and secondary causes of severe HDL deficiency and cardiovascular disease
Andrew S. Geller, Eliana Polisecki, Margaret R. Diffenderfer, et al.
Journal of Lipid Research (2018) Vol. 59, Iss. 12, pp. 2421-2435
Open Access | Times Cited: 61
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics
Emilie Westerlin Kjeldsen, Jesper Qvist Thomassen, Ruth Frikke‐Schmidt
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159063-159063
Open Access | Times Cited: 44
LCAT- targeted therapies: Progress, failures and future
Kaixu Yang, Junmin Wang, Hongjiao Xiang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112677-112677
Open Access | Times Cited: 32
Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020
Chiara Pavanello, Laura Calabresi
Current Opinion in Lipidology (2020) Vol. 31, Iss. 4, pp. 232-237
Closed Access | Times Cited: 44
High-density lipoproteins (HDL): Novel function and therapeutic applications
Maryam Darabi, Anatol Kontush
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159058-159058
Open Access | Times Cited: 35
HDL maturation and remodelling
Kwok Leung Ong, Blake J. Cochran, Bikash Manandhar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 4, pp. 159119-159119
Closed Access | Times Cited: 21
The biochemical and genetic diagnosis of lipid disorders
Ernst J. Schaefer, Andrew S. Geller, Gregory Endress
Current Opinion in Lipidology (2019) Vol. 30, Iss. 2, pp. 56-62
Closed Access | Times Cited: 31
The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
Roxana Nartea, Brînduşa Ilinca Mitoiu, Ioana Ghiorghiu
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3146-3167
Open Access | Times Cited: 10
Lipid efflux mechanisms, relation to disease and potential therapeutic aspects
David Castaño, Chutima Rattanasopa, Vera F. Monteiro-Cardoso, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 54-93
Closed Access | Times Cited: 27
Novel lecithin:cholesterol acyltransferase-based therapeutic approaches
Lita A. Freeman, Sotirios K. Karathanasis, Alan T. Remaley
Current Opinion in Lipidology (2020) Vol. 31, Iss. 2, pp. 71-79
Open Access | Times Cited: 21
LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred
Roopa Mehta, Daniel Elías-López, Alexandro J. Martagón, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 20
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency
Cecilia Vitali, Archna Bajaj, Christina Nguyen, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 3, pp. 100169-100169
Open Access | Times Cited: 13
Lecithin and cardiovascular health: a comprehensive review
Moyinoluwa Comfort Onaolapo, Olubunmi Alabi, Oyedayo Phillips Akano, et al.
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access | Times Cited: 2
Low LCAT Activity is Linked to Acute Decompensated Heart Failure and Mortality in CKD patients
Julia T. Stadler, Thomas Bärnthaler, Andrea Borenich, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 9, pp. 100624-100624
Open Access | Times Cited: 2
Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models
Masato Sasaki, Mina Delawary, Hidetaka Sakurai, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 41, Iss. 1, pp. 360-376
Open Access | Times Cited: 19
Identification of the interactions between specific genetic polymorphisms and nutrient intake associated with general and abdominal obesity in middle-aged adults
Yu‐Jin Kwon, Da Hyun Park, Ja‐Eun Choi, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 2, pp. 543-551
Closed Access | Times Cited: 11
Very low HDL levels: clinical assessment and management
Isabella Bonilha, Beatriz Luchiari, Wilson Nadruz, et al.
Archives of Endocrinology and Metabolism (2023) Vol. 67, Iss. 1, pp. 3-18
Open Access | Times Cited: 6
Large-scale, comprehensive plasma metabolomic analyses reveal potential biomarkers for the diagnosis of early-stage coronary atherosclerosis
Meng Sun, Wei Liu, Hao Jiang, et al.
Clinica Chimica Acta (2024) Vol. 562, pp. 119832-119832
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top